|
Vinblastine Sulfate
(vin blas' teen sul' fate).
C46H58N4O9·H2SO4 909.07 Vincaleukoblastine, sulfate (1:1) (salt); Vincaleukoblastine sulfate (1:1) (salt) DEFINITION
Vinblastine Sulfate contains NLT 96.0% and NMT 102.0% of C46H58N4O9·H2SO4, corrections being applied for loss in weight.
[CautionHandle Vinblastine Sulfate with great care, because it is a potent cytotoxic agent.
]
IDENTIFICATION
• A. Infrared Absorption
Analysis:
The sample specimen and reference standard are previously dried in vacuum at 60
Acceptance criteria:
Meets the requirements
• B. Identification TestsGeneral, Sulfate
Sample:
100 mg/mL in water
Acceptance criteria:
Meets the requirements
ASSAY
Change to read:
• Procedure
Solution A:
Diethylamine and water (14:986). Adjust with phosphoric acid to a pH of 7.5.
Solution B:
Acetonitrile and methanol (20:80)
Mobile phase:
Solution A and Solution B (38:62)
Standard solution:
0.4 mg/mL of USP Vinblastine Sulfate RS in water
System suitability solution:
0.4 mg/mL each of vincristine sulfate and vinblastine sulfate in water prepared as follows. Transfer USP Vincristine Sulfate RS
Sample solution:
0.4 mg/mL of Vinblastine Sulfate in water
Chromatographic system
Mode:
LC
Detector:
UV 262 nm
Columns
Precolumn:
Packed with porous silica gel; installed between the pump and the injector
Analytical:
4.6-mm × 15-cm; packing L1
Flow rate:
2 mL/min
Injection size:
20 µL
System suitability
Samples:
Standard solution and System suitability solution
Suitability requirements
Resolution:
NLT 4.0 between vincristine and vinblastine, System suitability solution
Relative standard deviation:
NMT 2.0%, Standard solution
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of vinblastine sulfate (C46H58N4O9·H2SO4) in the portion of Vinblastine Sulfate taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
96.0%102.0%, corrections being applied for loss in weight
IMPURITIES
• Organic Impurities
Mobile phase, System suitability solution, and System suitability:
Proceed as directed in the Assay.
Sample solution A:
Use the Sample solution prepared in the Assay.
Sample solution B:
16 µg/mL of vinblastine sulfate in water from Sample solution A
Chromatographic system
Mode:
LC
Detector:
UV 262 nm
Columns
Precolumn:
Packed with porous silica gel; installed between the pump and the injector
Analytical:
4.6-mm × 15-cm; packing L1
Flow rate:
2 mL/min
Injection size:
200 µL
Analysis
Samples:
Sample solution A and Sample solution B
Calculate the percentage of each individual impurity in the portion of Vinblastine Sulfate taken:
Result = [rUA/(SrUA + 25rUB)] × 100
Calculate the percentage of total impurities:
Result = [(SrUA/(SrUA + 25rUB)] × 100
Acceptance criteria
Individual impurities:
NMT 1.0%
Total impurities:
NMT 3.0%
SPECIFIC TESTS
• Loss on Drying
(See Thermal Analysis
[NoteIn this procedure, perform weighings rapidly with minimum exposure of the substances to air. ]
Sample:
10 mg
Analysis:
Determine the percentage of volatile substances by thermogravimetric analysis on an appropriately calibrated instrument. Heat the Sample at the rate of 5
Acceptance criteria:
It loses NMT 15.0% of its weight.
• Sterility Tests
• Bacterial Endotoxins Test
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in tight, light-resistant containers, and store in a freezer.
• Labeling:
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Change to read:
• USP Reference Standards
USP Endotoxin RS
[NoteNo loss on drying determination is needed. ]
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 5020
Pharmacopeial Forum: Volume No. 32(5) Page 1470
|